Semantic integration of clinical laboratory tests from electronic health records for deep phenotyping and biomarker discovery

npj Digital Medicine

Volumn 2, Issue 1, 2019, Pages

  Zhang, Xingmin Aaron ^a   Yates, Amy ^b   Vasilevsky, Nicole ^b   Gourdine, J P ^b   Callahan, Tiffany J ^c   Carmody, Leigh C ^a   Danis, Daniel ^a   Joachimiak, Marcin P ^d   Ravanmehr, Vida ^a   Pfaff, Emily R ^e   Champion, James ^e   Robasky, Kimberly ^e,f   Xu, Hao ^e   Fecho, Karamarie ^e   Walton, Nephi A ^g   Zhu, Richard L ^h   Ramsdill, Justin ^b   Mungall, Christopher J ^d   Köhler, Sebastian ^i,j   Haendel, Melissa A ^b,k   McDonald, Clement J ^l   Vreeman, Daniel J ^m,n   Peden, David B ^e,f   Bennett, Tellen D ^o   Feinstein, James A ^c   Martin, Blake ^o   Stefanski, Adrianne L ^c   Hunter, Lawrence E ^c   Chute, Christopher G ^h   Robinson, Peter N ^a,p   more..

^a JACKSON LABORATORY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

^f UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^g GEISINGER HEALTH SYSTEM   (United States)

^h JOHNS HOPKINS UNIVERSITY   (United States)

ⁱ BERLIN INSTITUTE OF HEALTH   (Germany)

^j Einstein Center Digital Future   (Germany)

^k OREGON STATE UNIVERSITY   (United States)

^l NATIONAL INSTITUTES OF HEALTH   (United States)

^m INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ REGENSTRIEF INSTITUTE   (United States)

^o Children's Hospital Colorado   (United States)

^p UNIVERSITY OF CONNECTICUT   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOMARKERS; INTEROPERABILITY; RECORDS MANAGEMENT; SOFTWARE TESTING;

BIO-MARKER DISCOVERY; COMPUTATIONAL RESOURCES; ELECTRONIC HEALTH; HEALTH RECORDS; HEALTHCARE INTEROPERABILITY; HIERARCHICAL STRUCTURES; LABORATORY TEST; ONTOLOGY TERMS; PHENOTYPING; SEMANTIC INTEGRATION;

LABORATORIES;

BIOLOGICAL MARKER; PREDNISONE;

ARTICLE; ASTHMA; CLINICAL LABORATORY; ELECTRONIC HEALTH RECORD; HUMAN; HYPERKALEMIA; HYPOALBUMINEMIA; HYPOKALEMIA; LABORATORY TEST; LEUKOCYTOSIS; LOGICAL OBSERVATION IDENTIFIERS NAMES AND CODES; MONOCYTOSIS; NEUTROPHILIA; PHENOTYPE; PRIORITY JOURNAL; SEMANTICS;

EID: 85089606359     PISSN: None     EISSN: 23986352     Source Type: Journal    
DOI: 10.1038/s41746-019-0110-4     Document Type: Article

References (40)

1. Denny, J. C., Bastarache, L. & Roden, D. M. Phenome-wide association studies as a tool to advance precision medicine. Annu. Rev. Genom. Hum. Genet. 17, 353–373 (2016).
2. Verma, A. et al. PheWAS and beyond: the landscape of associations with medical diagnoses and clinical measures across 38,662 individuals from Geisinger. Am. J. Hum. Genet. 102, 592–608 (2018).
3. Denny, J. C. et al. Variants near FOXE1 are associated with hypothyroidism and other thyroid conditions: using electronic medical records for genome- and phenome-wide studies. Am. J. Hum. Genet. 89, 529–542 (2011).
4. Dewey, F. E. et al. Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR study. Science 354, aaf6814 (2016).
5. Freimer, N. & Sabatti, C. The human phenome project. Nat. Genet. 34, 15–21 (2003).
6. Robinson, P. N. Deep phenotyping for precision medicine. Hum. Mutat. 33, 777–780 (2012).
7. Leroux, H., Metke-Jimenez, A. & Lawley, M. J. Towards achieving semantic interoperability of clinical study data with FHIR. J. Biomed. Semant. 8, 41 (2017).
8. McDonald, C. J. et al. LOINC, a universal standard for identifying laboratory observations: a 5-year update. Clin. Chem. 49, 624–633 (2003).
9. Köhler, S. et al. Expansion of the human phenotype ontology (HPO) knowledge base and resources. Nucleic Acids Res. 47, D1018–D1027 (2019).
10. Posey, J. E. et al. Resolution of disease phenotypes resulting from multilocus genomic variation. N. Engl. J. Med. 376, 21–31 (2017).
11. Son, J. H. et al. Deep phenotyping on electronic health records facilitates genetic diagnosis by clinical exomes. Am. J. Hum. Genet. 103, 58–73 (2018).
12. Köhler, S. et al. The human phenotype ontology in 2017. Nucleic Acids Res. 45, D865–D876 (2017).
13. Mandel, J. C., Kreda, D. A., Mandl, K. D., Kohane, I. S. & Ramoni, R. B. SMART on FHIR: a standards-based, interoperable apps platform for electronic health records. J. Am. Med. Inform. Assoc. 23, 899–908 (2016).
14. Robinson, P. N. & Bauer, S. Introduction to Bio-Ontologies. (CRC Press Inc., Boca Raton, FL, 2011).
15. Krishnan, J. A., Davis, S. Q., Naureckas, E. T., Gibson, P. & Rowe, B. H. An umbrella review: corticosteroid therapy for adults with acute asthma. Am. J. Med. 122, 977–991 (2009).
16. Aplasca, E. C. & Rammohan, M. The effect of prednisone on the levels of serum albumin of 20 patients with renal transplants. J. Am. Diet. Assoc. 86, 1404–1405 (1986).
17. Dale, D. C., Fauci, A. S., Guerry D, I. V. & Wolff, S. M. Comparison of agents producing a neutrophilic leukocytosis in man. Hydrocortisone, prednisone, endotoxin, and etiocholanolone. J. Clin. Invest. 56, 808–813 (1975).
18. Shoenfeld, Y., Gurewich, Y., Gallant, L. A. & Pinkhas, J. Prednisone-induced leukocytosis. Influence of dosage, method and duration of administration on the degree of leukocytosis. Am. J. Med. 71, 773–778 (1981).
19. Veltri, K. T. & Mason, C. Medication-induced hypokalemia. Pharm. Ther. 40, 185–190 (2015).
20. Smithson, J. et al.Drug induced muscle disorders. Aust. Pharm. 28, 1056 (2009).
21. Price, D. B. et al. Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study. Lancet Respir. Med. 3, 849–858 (2015).
22. Allen, S., Britton, J. R. & Leonardi-Bee, J. A. Association between antioxidant vitamins and asthma outcome measures: systematic review and meta-analysis. Thorax 64, 610–619 (2009).
23. Jolliffe, D. A. et al. Vitamin D supplementation to prevent asthma exacerbations: a systematic review and meta-analysis of individual participant data. Lancet Respir. Med 5, 881–890 (2017).
24. Thuesen, B. H. et al. Atopy, asthma, and lung function in relation to folate and vitamin B(12) in adults. Allergy 65, 1446–1454 (2010).
25. Yiallouros, P. K. et al. Low serum high-density lipoprotein cholesterol in childhood is associated with adolescent asthma. Clin. Exp. Allergy 42, 423–432 (2012).
26. Ramaraju, K., Krishnamurthy, S., Maamidi, S., Kaza, A. M. & Balasubramaniam, N. Is serum cholesterol a risk factor for asthma? Lung India 30, 295–301 (2013).
27. Ko, S.-H. et al. Lipid profiles in adolescents with and without asthma: Korea National Health and nutrition examination survey data. Lipids Health Dis. 17, 158 (2018).
28. Chen, Y. C. et al. Lipid profiles in children with and without asthma: interaction of asthma and obesity on hyperlipidemia. Diabetes Metab. Syndr. 7, 20–25 (2013).
29. Al-Shawwa, B., Al-Huniti, N., Titus, G. & Abu-Hasan, M. Hypercholesterolemia is a potential risk factor for asthma. J. Asthma 43, 231–233 (2006).
30. Cottrell, L., Neal, W. A., Ice, C., Perez, M. K. & Piedimonte, G. Metabolic abnormalities in children with asthma. Am. J. Respir. Crit. Care. Med. 183, 441–448 (2011).
31. Metke-Jimenez, A., Steel, J., Hansen, D. & Lawley, M. Ontoserver: a syndicated terminology server. J. Biomed. Semant. 9, 24 (2018).
32. Badrick, T. Evidence-based laboratory medicine. Clin. Biochem. Rev. 34, 43–46 (2013).
33. Pathak, J., Kho, A. N. & Denny, J. C. Electronic health records-driven phenotyping: challenges, recent advances, and perspectives. J. Am. Med. Inform. Assoc. 20, e206–11 (2013).
34. Ritchie, M. D. et al. Genome- and phenome-wide analyses of cardiac conduction identifies markers of arrhythmia risk. Circulation 127, 1377–1385 (2013).
35. Karnes, J. H. et al. Phenome-wide scanning identifies multiple diseases and disease severity phenotypes associated with HLA variants. Sci. Transl. Med. 9, 389 (2017).
36. Glueck, M. et al. PhenoLines: phenotype comparison visualizations for disease subtyping via topic models. IEEE. Trans. Vis. Comput. Graph. 24, 371–381 (2018).
37. Rajkomar, A. et al. Scalable and accurate deep learning with electronic health records. npj Digital Med. 1, 18 (2018).
38. Robinson, P. N. et al. Improved exome prioritization of disease genes through cross-species phenotype comparison. Genome Res. 24, 340–348 (2014).
39. Smedley, D. et al. Next-generation diagnostics and disease-gene discovery with the Exomiser. Nat. Protoc. 10, 2004–2015 (2015).
40. Smedley, D. et al. A whole-genome analysis framework for effective identification of pathogenic regulatory variants in Mendelian disease. Am. J. Hum. Genet. 99, 595–606 (2016).